| Ark gains on hopes for cancer drug | 31-Jul-2008 | The Independent |
| Need to know | 31-May-2008 | Times |
| Ark perks up after regulators say brain tumour g... | 06-Jan-2007 | Telegraph |
| Database | 14-Oct-2006 | Telegraph |
| Ark breaks new ground in tackling cancer care si... | 20-Feb-2006 | Times |
| Ark nudge | 01-Sep-2004 | Guardian |
| City briefs | 01-Sep-2004 | Telegraph |
| Maxwell escapes bankruptcy | 18-Jun-2004 | Guardian |
| Drug keeps people alive longer | 08-Jun-2004 | Telegraph |
| Ark's gene therapy go-ahead | 07-May-2004 | Guardian |
| Merlin tries to regain its magic touch | 28-Mar-2004 | Sunday Times |
| IPO market stirs as companies reveal plans | 04-Mar-2004 | Times |
| Ark floats at the second attempt | 04-Mar-2004 | Telegraph |
| Punters keen to climb aboard Ark | 03-Mar-2004 | Daily Mail |
| Flotation could value Ark at £140m | 08-Apr-2002 | The Herald |
| Ark braves biotech blues by coming to market | 07-Apr-2002 | Independent on Sunday |
| Ark Therapeutics plans £140m London listing | 07-Apr-2002 | Sunday Telegraph |
| Business Digest | 07-Apr-2002 | Sunday Times |
| Currency | UK Pounds |
| Share Price | 0.37p |
| Change Today | -0.040p |
| % Change | -9.76 % |
| 52 Week High | 3.58 |
| 52 Week Low | 0.36 |
| Volume | 75,309 |
| Shares Issued | 209.28m |
| Market Cap | £0.77m |
| Beta | 0.57 |
| RiskGrade | 833 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:45 | 309 @ 0.37p |
| 15:59 | 75,000 @ 0.44p |
| CEO | Martyn Williams |
| CFO | Russell Banks |
You are here: research